Relafen Interactions
There are 364 drugs known to interact with Relafen (nabumetone), along with 13 disease interactions, and 3 alcohol/food interactions. Of the total drug interactions, 95 are major, 261 are moderate, and 8 are minor.
- View all 364 medications that may interact with Relafen
- View Relafen alcohol/food interactions (3)
- View Relafen disease interactions (13)
Most frequently checked interactions
View interaction reports for Relafen (nabumetone) and the medicines listed below.
- Cymbalta (duloxetine)
- Cymbalta (duloxetine)
- Flexeril (cyclobenzaprine)
- Flexeril (cyclobenzaprine)
- gabapentin
- gabapentin
- lisinopril
- lisinopril
- Lyrica (pregabalin)
- Lyrica (pregabalin)
- metformin
- metformin
- Neurontin (gabapentin)
- Neurontin (gabapentin)
- omeprazole
- omeprazole
- prednisone
- prednisone
- Singulair (montelukast)
- Singulair (montelukast)
- Synthroid (levothyroxine)
- Synthroid (levothyroxine)
- tramadol
- tramadol
- trazodone
- trazodone
- Vitamin D3 (cholecalciferol)
- Vitamin D3 (cholecalciferol)
- Xanax (alprazolam)
- Xanax (alprazolam)
Relafen alcohol/food interactions
There are 3 alcohol/food interactions with Relafen (nabumetone).
Relafen disease interactions
There are 13 disease interactions with Relafen (nabumetone) which include:
- asthma
- fluid retention
- GI toxicity
- rash
- renal toxicities
- thrombosis
- liver disease
- anemia
- heart failure
- hepatotoxicity
- hyperkalemia
- hypertension
- platelet aggregation inhibition
More about Relafen (nabumetone)
- Relafen consumer information
- Compare alternatives
- Reviews (38)
- Drug images
- Latest FDA alerts (4)
- Side effects
- Dosage information
- During pregnancy
- Drug class: Nonsteroidal anti-inflammatory drugs
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.